Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28549783

Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Jul
First author
Mody R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Jul;18(7):845-846. doi: 10.1016/S1470-2045(17)30337-6.
    note
    Source null
    related pmid
    28549784
    relationship
    Comment in

Authors and identifiers

  1. name
    Mody R
    type
    Author
  2. name
    Naranjo A
    type
    Author
  3. name
    Van Ryn C
    type
    Author
  4. name
    Yu AL
    type
    Author
  5. name
    London WB
    type
    Author
  6. name
    Shulkin BL
    type
    Author
  7. name
    Parisi MT
    type
    Author
  8. name
    Servaes SE
    type
    Author
  9. name
    Diccianni MB
    type
    Author
  10. name
    Sondel PM
    type
    Author
  11. name
    Bender JG
    type
    Author
  12. name
    Maris JM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mody R
    type
    Author
  2. name
    Naranjo A
    type
    Author
  3. name
    Van Ryn C
    type
    Author
  4. name
    Yu AL
    type
    Author
  5. name
    London WB
    type
    Author
  6. name
    Shulkin BL
    type
    Author
  7. name
    Parisi MT
    type
    Author
  8. name
    Servaes SE
    type
    Author
  9. name
    Diccianni MB
    type
    Author
  10. name
    Sondel PM
    type
    Author
  11. name
    Bender JG
    type
    Author
  12. name
    Maris JM
    type
    Author
bibliography ids
  1. nci-bib-2c860618fa31b8096b0814c1
book metadata
content sha256
327bc705bfa7f06ca0b87a30fe85c1484825e5c44df73692207e8d73cc6bd04c
document type
citation
dois
  1. 10.1016/S1470-2045(17)30355-8
electronic publication date
display
2017 May 23
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28549783
immutable id
pubmed:28549783@327bc705bfa7f06ca0b87a30fe85c1484825e5c44df73692207e8d73cc6bd04c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
946-957
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Jul;18(7):845-846. doi: 10.1016/S1470-2045(17)30337-6.
    note
    Source null
    related pmid
    28549784
    relationship
    Comment in
outcomes validated
false
pmid
28549783
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
7f9758e6d83b61640aa02f3f05edd704be84e1044b7eb4f5810bf9537357bfc3
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Jul
precision
month
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28549783/
title
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.

Preserved source evidence · Not medical advice